Mapping brain connectivity using a new imaging technique
Resting-state functional connectivity mapping using Magnetic Particle Imaging (MPI)
This study is exploring a new way to take clearer pictures of the brain using a special imaging technique called Magnetic Particle Imaging, which could help us understand how different parts of the brain work together when you're not doing anything, and it might lead to better tools for diagnosing conditions like Alzheimer's disease.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10914130 on NIH RePORTER |
What this research studies
This research investigates a novel imaging method called Magnetic Particle Imaging (MPI) to better understand how different parts of the brain communicate with each other at rest. By using super-paramagnetic iron oxide nanoparticles, the study aims to enhance the clarity of brain images compared to traditional methods like functional MRI. The goal is to validate MPI's ability to detect fluctuations in blood volume in the brain, which can help map functional connectivity networks. This could lead to improved diagnostic tools for conditions like Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with other neurological conditions unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide more accurate brain imaging techniques that enhance the diagnosis and understanding of Alzheimer's disease.
How similar studies have performed: While MPI is a relatively novel approach, preliminary studies have shown promise in animal models, indicating potential for success in human applications.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Drago, John Michael — Harvard Medical School
- Study coordinator: Drago, John Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.